Medical Developments International LtdShs Aktie 1727778 / AU000000MVP2
0.35
USD
-0.04
USD
-9.61%
24.07.2024
NASO
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Medical Developments International Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Medical Developments International LtdShs | 0.00 | 0.00 | AUD |
| 2023 | Medical Developments International LtdShs | 0.00 | 0.00 | AUD |
| 2022 | Medical Developments International LtdShs | 0.00 | 0.00 | AUD |
| 2021 | Medical Developments International LtdShs | 0.00 | 0.00 | AUD |
| 2020 | Medical Developments International LtdShs | 0.29 | 0.02 | AUD |
| 2019 | Medical Developments International LtdShs | 0.75 | 0.04 | AUD |
| 2018 | Medical Developments International LtdShs | 0.69 | 0.04 | AUD |
| 2017 | Medical Developments International LtdShs | 0.81 | 0.04 | AUD |
| 2016 | Medical Developments International LtdShs | 0.66 | 0.04 | AUD |
| 2015 | Medical Developments International LtdShs | 0.00 | 0.00 | AUD |
Gewinn je Aktie- Medical Developments International LtdShs
| -0.5 24 | -0.1 23 | -0.2 22 | -0.2 21 | 0.0 20 | 0.0 19 | 0.0 18 |
Umsatz je Aktie- Medical Developments International LtdShs
| 0.4 24 | 0.4 23 | 0.3 22 | 0.4 21 | 0.3 20 | 0.3 19 | 0.3 18 |
KGV- Medical Developments International LtdShs
| 1217 20 | 330 19 | 1463 18 |
Medical Developments International LtdShs: Die Aktie (in AUD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | -0.46 | -0.06 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 |
| Gewinn je Aktie unverwässert | -0.46 | -0.06 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 |
| Gewinn je Aktie verwässert | -0.46 | -0.06 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 |
| Dividende pro Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.04 |
| Gesamtdividendenausschüttung in Mio. | 0.00 | 0.00 | 0.00 | 0.00 | 2.07 | 1.72 | 1.24 |
Medical Developments International LtdShs: Unternehmenskennzahlen (in AUD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 0.37 | 0.37 | 0.30 | 0.35 | 0.33 | 0.31 | 0.28 |
| KGV (Jahresendkurs, EPS unverwässert) | - | - | - | - | 1’216.56 | 329.91 | 1’463.14 |
| KGV (Jahresendkurs, EPS verwässert) | - | - | - | - | 1’216.56 | 332.07 | 1’463.14 |
| KGV (Jahresendkurs) | - | - | - | - | 1’216.56 | 329.91 | 1’463.14 |
| Dividendenrendite Jahresende in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.29 | 0.75 | 0.69 |
| Eigenkapitalquote in % | 71.71 | 74.27 | 56.53 | 68.18 | 45.69 | 48.16 | 42.47 |
| Fremdkapitalquote in % | 28.29 | 25.73 | 43.47 | 31.82 | 54.31 | 51.84 | 57.53 |
Medical Developments International LtdShs: GuV (in Mio. AUD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 33.15 | 32.34 | 22.37 | 25.27 | 22.54 | 20.88 | 17.46 |
| Umsatzveränderung in % | 2.51 | 44.56 | -11.49 | 12.15 | 7.95 | 19.56 | -4.83 |
| Bruttoergebnis vom Umsatz | -2.50 | -2.52 | -2.63 | 16.67 | 13.74 | 12.92 | 11.20 |
| Bruttoergebnisveränderung in % | 0.64 | 4.48 | - | 21.37 | 6.32 | 15.35 | -3.26 |
| Operatives Ergebnis | -16.87 | -20.27 | -15.27 | -5.24 | 1.87 | 2.89 | 1.51 |
| Veränderung Operatives Ergebnis in % | 16.80 | -32.77 | -191.45 | - | -35.28 | 91.53 | -57.27 |
| Ergebnis vor Steuern | -32.93 | -7.49 | -15.91 | -14.98 | 0.32 | 1.55 | 0.30 |
| Veränderung Ergebnis vor Steuern in % | -339.48 | 52.90 | -6.21 | - | -79.30 | 415.28 | -87.78 |
| Ergebnis nach Steuer | -40.99 | -5.61 | -12.41 | -12.57 | 0.38 | 1.04 | 0.24 |
| Veränderung Ergebnis nach Steuer in % | -630.83 | 54.79 | 1.26 | - | -63.49 | 327.16 | -86.65 |
Medical Developments International LtdShs: Bilanz (in Mio. AUD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 18 | 28 | 44 | 32 | 52 | 48 | 29 |
| Langzeit Gesamtverbindlichk. pro Aktie | 0.10 | 0.14 | 0.45 | 0.34 | 0.63 | 0.58 | 0.36 |
| Eigenkapital | 46 | 81 | 57 | 68 | 43 | 45 | 21 |
| Veränderung Eigenkapital in % | -43.76 | 41.92 | -16.11 | 57.60 | -2.80 | 111.91 | -2.59 |
| Bilanzsumme | 64 | 109 | 101 | 100 | 95 | 93 | 50 |
| Veränderung Bilanzsumme in % | -41.75 | 8.02 | 1.18 | 5.61 | 2.44 | 86.87 | 18.64 |
Medical Developments International LtdShs: Sonstige Angaben (in AUD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -0.46 | -0.06 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -614.04 | 61.17 | 5.12 | -3’298.18 | -64.29 | 305.26 | -87.21 |
| Gewinn je Aktie (verwässert) | -0.46 | -0.06 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 |
| Veränderung Gewinn je Aktie (verwässert) in % | -614.04 | 61.17 | 5.12 | -3’298.18 | -64.05 | 302.63 | -87.21 |
| Anzahl Mitarbeiter | - | - | - | 68 | 65 | 58 | 55 |
| Veränderung Anzahl Mitarbeiter in % | - | - | - | 4.62 | 12.07 | 5.45 | 3.77 |
Medical Developments International LtdShs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Medical Developments International LtdShs | Quartalszahlen | 20.02.2025 |
| Medical Developments International LtdShs | Quartalszahlen | 21.08.2025 |
| Medical Developments International LtdShs | Quartalszahlen | 19.02.2026 |
| Medical Developments International LtdShs | Quartalszahlen | 20.08.2026 |
Medical Developments International LtdShs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Hauptversammlung | Annual General Meeting | 24.10.2024 |
| Quartalszahlen | Q4 2024 Earnings Release | 25.08.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 28.02.2024 |
| Hauptversammlung | Annual General Meeting | 26.10.2023 |
| Quartalszahlen | Q4 2023 Earnings Release | 30.08.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 23.02.2023 |
| Hauptversammlung | Annual General Meeting | 27.10.2022 |
| Quartalszahlen | Q4 2022 Earnings Release | 25.08.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 24.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 82.84 |
| David John Williams | 5.60 |
| Lawn Views Pty Ltd. | 5.38 |
| FIL Investment Management (Hong Kong) Ltd. | 4.28 |
| Fidelity Funds SICAV - Pacific Fund | 2.59 |
| Netwealth Investments Ltd. | 2.49 |
| FIL Investment Management (Australia) Ltd. | 2.46 |
| Russell Kay Hancock | 1.56 |
| Gordon Naylor, MBA, CPA | 1.16 |
| M&G Investment Funds (3) - Recovery Fund | 1.00 |
| Kidder Peabody Pty Ltd. | 0.95 |
| NEF - Pacific Equity | 0.83 |
| Payne Media Pty Ltd. | 0.78 |
| Fidelity Australian High Conviction Fund | 0.77 |
| Alistair William Strong | 0.57 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 55 | 58 | 65 | 68 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.32 | 0.36 | 0.35 | 0.37 | 0.00 |
Bilanz (in Mio. AUD) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 9 | 35 | 26 | 47 | 34 |
| Summe Anlagevermögen | 41 | 57 | 69 | 53 | 67 |
| Summe Aktiva | 50 | 93 | 95 | 100 | 101 |
Bilanz (in Mio. AUD) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 29 | 48 | 52 | 32 | 44 |
| Summe Eigenkapital | 21 | 45 | 43 | 68 | 57 |
| Summe Passiva | 50 | 93 | 95 | 100 | 101 |
Adresse
| 4 Caribbean Drive, 3179 Scoresby | |
| Telefon | +61 (3) 9547-1888 |
| Fax | +61 (3) 9547-0262 |
| URL | http://www.medicaldev.com |
Management
|
Anastasia Tan
Head-Operations & Supply Chain |
|
Anita James
Chief Financial Officer |
|
Brent MacGregor
Chief Executive Officer |
|
Christine Emmanuel-Donnelly
Independent Non-Executive Director |
|
Damian Meagher
Head-Quality & Regulatory Affairs |
|
Gordon Naylor
Non-Executive Chairman |
|
Leon Gregory Hoare
Independent Non-Executive Director |
|
Richard Betts
Non-Executive Director |
|
Russell Basser
Director |
|
Scott Courtney
Chief Scientific Officer |
|
Sue Anne Yee
Head-Medical Affairs & Clinical Development |
|
Tara Eaton
Secretary & General Counsel |
|
Tony Wheal
Head-People & Culture |